公开(公告)号：US11801280B2

公开(公告)日：2023-10-31

申请号：US17415969

申请日：2020-04-08

申请人： HUBEI MONYAN PHARMACEUTICAL CO., LTD.

发明人： Min Zhang

IPC分类号： A61K36/899 ,  A61K9/08 ,  A61K36/232 ,  A61K36/296 ,  A61K36/48 ,  A61K36/481 ,  A61K36/484 ,  A61K36/487 ,  A61K36/714 ,  A61K36/74 ,  A61K36/77 ,  A61K36/8968 ,  A61K9/00

CPC分类号： A61K36/899 ,  A61K9/0053 ,  A61K9/08 ,  A61K36/232 ,  A61K36/296 ,  A61K36/48 ,  A61K36/481 ,  A61K36/484 ,  A61K36/487 ,  A61K36/714 ,  A61K36/74 ,  A61K36/77 ,  A61K36/8968 ,  A61K2236/331 ,  A61K2236/333 ,  A61K2236/37 ,  A61K2236/51

摘要： The present invention relates to a drug for treating leukopenia, its preparation method and use thereof. The drug of the invention is prepared from 200-30 parts by weight of Folium Epimedii, 100-160 parts by weight of Fructus Psoraleae, 60-120 parts by weight of Radix Aconiti Lateralis Preparata (Processed), 200-300 parts by weight of Fructus Lycii, 200-300 parts by weight of Radix Astragali, 200-300 parts by weight of Caulis Spatholobi, 200-300 parts by weight of Radix Rubiae, 100-160 parts by weight of Radix Angelicae Sinensis, 200-300 parts by weight of Rhizoma Phragmitis, 100-160 parts by weight of Radix Ophiopogonis and 100-160 parts by weight of Radix et Rhizoma Glycyrrhizae. The drug of the invention comprises chemical substances with weight ratios as follows: Leucine:guanosine:psoralenoside:isopsoralenoside:calycosin-7-glucoside:liquiritin:icariin A:1,3-dihydroxyl-2-hydroxymethylanthraquinone:epimedin A:epimedin B:epimedin C:icariin:1,3,6-trihydroxy-2-methylanthraquinone:glycyrrhizic acid=(0.13-0.27):(0.04-0.11):(0.11-0.34):(0.09-0.34):(0.05-0.11):(0.16-0.26):(0.09-0.12):(0.17-0.35):(0.11-0.16):(0.17-0.26):(0.49-0.59):1.00:(0.16-0.24):(0.08-0.14).

公开(公告)号：US11738062B2

公开(公告)日：2023-08-29

申请号：US17271567

申请日：2019-08-26

申请人： ALPHA OASIS LLC

发明人： Hong Ye ,  Chengbao Ye

IPC分类号： A61K36/714 ,  A61P19/02 ,  A61K36/232 ,  A61K36/237 ,  A61K47/30

CPC分类号： A61K36/714 ,  A61K36/232 ,  A61K36/237 ,  A61P19/02 ,  A61K47/30 ,  A61K2236/331

摘要： The present invention provides a composition of a mixture comprising Radix Aconiti, Radix Aconiti Kusnezoffii, Rhizoma et Radix Notopterygii and Radix Angelicae Pubescentis, and an herbal extract composition of a mixture comprising Radix Aconiti, Radix Aconiti Kusnezoffii, Rhizoma et Radix Notopterygii and Radix Angelicae Pubescentis. A method for preparing the herbal extract composition and a product by the method thereof is further provided by the present invention. The herbal extract composition is useful for alleviating pain and treating diseases such as rheumatoid arthritis (RA) or osteoarthritis (OA).

公开(公告)号：US20190192642A1

公开(公告)日：2019-06-27

申请号：US15853562

申请日：2017-12-22

申请人： PRODUITS NATURASENSE INC.

发明人： Samuel GLEN ,  Barbara J. JOHNSTON ,  Lynda THERRIEN BERTHIAUME ,  Molly SHARMA

IPC分类号： A61K38/54 ,  A61K36/75 ,  A61K36/45 ,  A61K36/88 ,  A61K36/30 ,  A61K36/28 ,  A61K36/81 ,  A61K36/185 ,  A61K33/28 ,  A61K36/23 ,  A61K36/714 ,  A61K33/04 ,  A61K47/44 ,  A61K47/10 ,  A61K47/12 ,  A61K47/26

CPC分类号： A61K38/54 ,  A61K33/04 ,  A61K33/28 ,  A61K36/185 ,  A61K36/23 ,  A61K36/28 ,  A61K36/30 ,  A61K36/45 ,  A61K36/714 ,  A61K36/75 ,  A61K36/81 ,  A61K36/88 ,  A61K47/10 ,  A61K47/12 ,  A61K47/26 ,  A61K47/44

摘要： The present document describes a non-carcinogenic cream for delivery of active ingredients in the dermis of a patient, which comprises a synergistic combination of about 10 to 25% of oil about 10 to 25% of emulsifier about 1 to 12% of preservative about 45 to 80% of water, aloe water or hamamelis water; and about 1 to 25% of at least one homeopathic active ingredient chosen from pancreatinum, ruta graveolens, ledum palustre, colchicum autumnale, symphytum officinalis, salix alba, harpagophytum, bryonia, capsicum, rhododendron, benzoic acid, salicilicum acid, arnica montana, atropa belladonna, achillea millefolium, hamamelis, agaricus, aesculus, mercurius solubilis, mercurius iodatus, conium maculatum, echinacea angustifolia, echinacea purpurea, scrofularia nosada, pulsatilla, aconitum napellus, hypericum perforatum, bellis perennis, matricaria chamomilla, ranunculus, phytolacca decandra, dulcamara solanum, kalmia, actea racemosa, spigelia, gnaphalium, calendula officinalis, hepar sulphuris, somniferrum, calcarea fluorica, thiosinaminum, hydrastis, arctium lappa, gallium aparine, urtica urens, aloe, graphite, petroleum or a synergistic combination thereof.

公开(公告)号：US09687518B2

公开(公告)日：2017-06-27

申请号：US14989788

申请日：2016-01-06

申请人： Biologische Heilmittel Heel GmbH

发明人： Anna Aletta Smit

IPC分类号： A61K36/00 ,  A61K36/81 ,  A61K36/185 ,  A61K36/714 ,  A61K36/28 ,  A61K33/06 ,  A61K33/28 ,  A61K36/30 ,  A61K36/22 ,  A61K36/66 ,  A61K33/04 ,  A61K31/7076 ,  A61K35/54 ,  A61K35/51 ,  A61K35/50 ,  A61K9/00 ,  A61K31/385 ,  A61K36/38

CPC分类号： A61K36/81 ,  A61K9/0019 ,  A61K31/385 ,  A61K31/7076 ,  A61K33/04 ,  A61K33/06 ,  A61K33/28 ,  A61K35/50 ,  A61K35/51 ,  A61K35/54 ,  A61K36/185 ,  A61K36/22 ,  A61K36/28 ,  A61K36/30 ,  A61K36/38 ,  A61K36/66 ,  A61K36/714 ,  A61K2300/00

摘要： The present invention concerns the field of therapy of muscle, joint and/or skeletal diseases. In particular, the invention relates to a composition comprising a first solution comprising preparations of Aconitum napellus, Arnica montana, radix, Bellis perennis, Belladonna, Calendula officinalis, Chamomilla, Echinacea, Echinacea purpurea, Hamamelis virginiana, Hepar sulfuris calcareum, Hypericum perforatum, Mercuris solubilis, Millefolium, and Symphytum officinale, and a second solution comprising preparations of Arnica montana, radix, Dulcamara, Rhus toxicodendron, Sanguinaria Canadensis, and Sulphur. Further provided is a method of treating and/or preventing the progression of a disease comprising administering to a subject in need of a treatment a therapeutically effective amount of the said composition or said first and said second solution. The invention also contemplates a kit comprising said first and said second solution.

公开(公告)号：US20160113986A1

公开(公告)日：2016-04-28

申请号：US14989788

申请日：2016-01-06

申请人： Biologische Heilmittel Heel GmbH

发明人： Anna Aletta Smit

IPC分类号： A61K36/81 ,  A61K36/28 ,  A61K36/185 ,  A61K33/06 ,  A61K33/28 ,  A61K36/30 ,  A61K36/22 ,  A61K36/66 ,  A61K33/04 ,  A61K31/385 ,  A61K31/7076 ,  A61K35/54 ,  A61K35/51 ,  A61K35/50 ,  A61K36/714

CPC分类号： A61K36/81 ,  A61K9/0019 ,  A61K31/385 ,  A61K31/7076 ,  A61K33/04 ,  A61K33/06 ,  A61K33/28 ,  A61K35/50 ,  A61K35/51 ,  A61K35/54 ,  A61K36/185 ,  A61K36/22 ,  A61K36/28 ,  A61K36/30 ,  A61K36/38 ,  A61K36/66 ,  A61K36/714 ,  A61K2300/00

摘要： The present invention concerns the field of therapy of muscle, joint and/or skeletal diseases. In particular, the invention relates to a composition comprising a first solution comprising preparations of Aconitum napellus, Arnica montana, radix, Bellis perennis, Belladonna, Calendula officinalis, Chamomilla, Echinacea, Echinacea purpurea, Hamamelis virginiana, Hepar sulfuris calcareum, Hypericum perforatum, Mercuris solubilis, Millefolium, and Symphytum officinale, and a second solution comprising preparations of Arnica montana, radix, Dulcamara, Rhus toxicodendron, Sanguinaria Canadensis, and Sulphur. Further provided is a method of treating and/or preventing the progression of a disease comprising administering to a subject in need of a treatment a therapeutically effective amount of the said composition or said first and said second solution. The invention also contemplates a kit comprising said first and said second solution.

公开(公告)号：US20160015630A1

公开(公告)日：2016-01-21

申请号：US14800466

申请日：2015-07-15

申请人： Oxy Bump Corporation

发明人： Shamila Hunter

IPC分类号： A61K9/00 ,  A61K36/88 ,  A61K33/14 ,  A61K31/417 ,  A61K36/185 ,  A61K33/24 ,  A61K36/64 ,  A61K36/13 ,  A61K36/714 ,  A61K33/42 ,  A61K33/04 ,  A61K33/00 ,  A61K33/18

CPC分类号： A61K9/0043 ,  A61K9/08 ,  A61K31/417 ,  A61K33/00 ,  A61K33/14 ,  A61K36/00 ,  A61K36/13 ,  A61K36/185 ,  A61K36/64 ,  A61K36/714 ,  A61K36/88 ,  A61K41/0004 ,  A61K45/06 ,  A61K47/02 ,  A61K2300/00

摘要： An oxygenated saline composition is provided comprising stabilized oxygen, sodium chloride (aqueous saline solution), and optionally one or more homeopathic components. The stabilized oxygen can include quad-atomic oxygen. Also provided is a method for treating, reducing or preventing nasal and/or sinus congestion, allergy, dryness, throat irritation, skin irritation, wounds, or eye irritation comprising administering to an individual in need thereof an effective amount of an oxygenated saline composition comprising stabilized oxygen, aqueous saline solution, and optionally one or more homeopathic components, wherein the composition is administered by intranasal spraying, throat spray, skin spray, sublingually, or by eye drops.

摘要翻译： 提供了一种氧合盐水组合物，其包括稳定的氧，氯化钠（盐水溶液）和任选的一种或多种顺势疗法组分。 稳定的氧气可以包括四原子氧。 还提供了治疗，减少或预防鼻和/或窦充血，过敏，干燥，咽喉刺激，皮肤刺激，伤口或眼睛刺激的方法，包括向有需要的个体施用有效量的含氧盐水组合物，其包含 稳定的氧气，盐水溶液和任选的一种或多种顺势疗法组分，其中所述组合物通过鼻内喷雾，咽喉喷雾，皮肤喷雾，舌下或滴眼剂施用。

公开(公告)号：US20150374778A1

公开(公告)日：2015-12-31

申请号：US14846786

申请日：2015-09-06

申请人： Mingchun Xiao

发明人： Mingchun Xiao

IPC分类号： A61K36/9068 ,  A61K36/8988 ,  A61K36/07 ,  A61K36/752 ,  A61K36/284 ,  A61K36/484 ,  A61K36/575 ,  A61K36/236 ,  A61K36/232 ,  A61K36/237 ,  A61K36/268 ,  A61K36/85 ,  A61K36/185 ,  A61K36/46 ,  A61K36/21 ,  A61K36/515 ,  A61K36/54 ,  A61K36/258 ,  A61K36/65 ,  A61K36/804 ,  A61K36/481 ,  A61K36/714 ,  A61K36/12 ,  A61K36/884 ,  A61K36/8945 ,  A61K36/882 ,  A61K36/9062 ,  A61K36/734 ,  A61K36/8888

CPC分类号： A61K36/9068 ,  A23F3/163 ,  A61K36/07 ,  A61K36/076 ,  A61K36/12 ,  A61K36/185 ,  A61K36/21 ,  A61K36/232 ,  A61K36/233 ,  A61K36/236 ,  A61K36/237 ,  A61K36/258 ,  A61K36/268 ,  A61K36/284 ,  A61K36/46 ,  A61K36/48 ,  A61K36/481 ,  A61K36/482 ,  A61K36/484 ,  A61K36/515 ,  A61K36/53 ,  A61K36/532 ,  A61K36/535 ,  A61K36/538 ,  A61K36/539 ,  A61K36/54 ,  A61K36/575 ,  A61K36/65 ,  A61K36/66 ,  A61K36/68 ,  A61K36/71 ,  A61K36/714 ,  A61K36/734 ,  A61K36/752 ,  A61K36/804 ,  A61K36/85 ,  A61K36/88 ,  A61K36/882 ,  A61K36/884 ,  A61K36/888 ,  A61K36/8884 ,  A61K36/8888 ,  A61K36/8905 ,  A61K36/8945 ,  A61K36/8988 ,  A61K36/8998 ,  A61K36/906 ,  A61K36/9062 ,  A61K36/9064 ,  A61K36/9066 ,  A61K2300/00

摘要： A pharmaceutical composition for treating cancers and preparation method thereof. Said composition for treating cancers contains Chinese medicinal materials including Rhizoma Pinelliae, Rhizoma Arisaematis, Rhizoma Gastrodiae etc., and said preparation method is in accordance with a conventional Chinese medicinal preparation method, manufacturing said composition to form any one of the ordinary oral preparations.

摘要翻译： 一种治疗癌症的药物组合物及其制备方法。 所述治疗癌症的组合物含有中药材，包括苦参，苦参，天麻等，所述制备方法按照常规的中药制备方法，制备所述组合物以形成任何一种普通口服制剂。

公开(公告)号：US20150374773A1

公开(公告)日：2015-12-31

申请号：US14850054

申请日：2015-09-10

申请人： NEURAGEN CORP.

发明人： Alexander MCLELLAN

IPC分类号： A61K36/714 ,  A61K33/42 ,  A61K36/22 ,  A61K36/18 ,  A61K36/38 ,  A61K36/066

CPC分类号： A61K36/714 ,  A61K9/0014 ,  A61K9/06 ,  A61K9/12 ,  A61K33/42 ,  A61K36/02 ,  A61K36/066 ,  A61K36/11 ,  A61K36/18 ,  A61K36/22 ,  A61K36/38 ,  A61K41/0004 ,  A61K45/06 ,  A61K47/44 ,  A61K2300/00

摘要： The present invention provides a method of treating neuropathic pain by administering a topical homeopathic composition to a mammalian subject. The homeopathic formulation contains homeopathic active ingredients comprising Hypericum perforatum in a base of essential oils which facilitate delivery of the homeopathic ingredient through the skin.

摘要翻译： 本发明提供了通过向哺乳动物受试者施用局部顺势疗法组合物来治疗神经性疼痛的方法。 顺势疗法制剂含有顺势疗法活性成分，其包含精油基质中的金丝桃属贯穿孔，促进顺势疗法成分通过皮肤递送。

公开(公告)号：US20060110470A1

公开(公告)日：2006-05-25

申请号：US10518728

申请日：2002-09-29

申请人： Wenquan Fang

发明人： Wenquan Fang

IPC分类号： A61K36/906 ,  A61K36/254 ,  A61K36/54 ,  A61K36/537 ,  A61K36/48 ,  A61K36/258

CPC分类号： A61K35/646 ,  A61K36/232 ,  A61K36/258 ,  A61K36/484 ,  A61K36/505 ,  A61K36/537 ,  A61K36/65 ,  A61K36/714 ,  A61K36/725 ,  A61K36/79 ,  A61K36/8905 ,  A61K36/9064 ,  A61K2300/00

摘要： The present invention relates to compound Chinese medicine preparation, and is especially one drug addiction stopping Chinese medicine prepared with red sage, mankshood, cassia, amomum fruit and other Chinese medicinal materials. The present invention also discloses its preparation process and application.

摘要翻译： 本发明涉及复方中药制剂，特别是一种药物成瘾药物，用中药制剂制备，具有红枣，芒果，决明子，淀粉等中药材。 本发明还公开了其制备方法和应用。

公开(公告)号：US06790464B2

公开(公告)日：2004-09-14

申请号：US10345158

申请日：2003-01-16

申请人： Koon Yong Kuok ,  Hien Ly

发明人： Koon Yong Kuok ,  Hien Ly

IPC分类号： A61K3578

CPC分类号： A61K36/899 ,  A23L33/105 ,  A61K36/07 ,  A61K36/074 ,  A61K36/076 ,  A61K36/11 ,  A61K36/185 ,  A61K36/232 ,  A61K36/233 ,  A61K36/237 ,  A61K36/25 ,  A61K36/268 ,  A61K36/324 ,  A61K36/328 ,  A61K36/36 ,  A61K36/428 ,  A61K36/46 ,  A61K36/48 ,  A61K36/481 ,  A61K36/484 ,  A61K36/539 ,  A61K36/54 ,  A61K36/62 ,  A61K36/64 ,  A61K36/65 ,  A61K36/68 ,  A61K36/708 ,  A61K36/71 ,  A61K36/714 ,  A61K36/716 ,  A61K36/744 ,  A61K36/756 ,  A61K36/804 ,  A61K36/882 ,  A61K36/884 ,  A61K36/8945 ,  A61K36/8964 ,  A61K36/8965 ,  A61K36/8994 ,  A61K38/09 ,  A61K2300/00

摘要： Methods and compositions are disclosed for prevention or treatment of prostate disorders and ameliorating symptoms thereof, including prostatitis, benign prostate hyperplasia and prostatic carcinoma. The methods comprise administering a composition of matter comprising the following herbal and other components: Radix Asparagi; Radix Angelicae Pubescentis; Radix Trichosanthis; Radix Scuttellariae; Radix Angelicae Sinensis; Radix Dipsaci; Cortex Eucommiae; Medulla Junci; Rhizoma Anemarrhenae; Caulis Akebiae; Herba Dianthi; Semen Plantaginis; Cortex Phellodendri (fried); Radix et Rhizoma Rhei; Rhizoma seu Radix Notopterygii; Olibanum; Fructus Gardeniae; Radix Astragali seu Hedysari; Rhizoma Cimicifugae; Radix Bupleuri; Myrrha; Gypsum Fibrosun; Radix Rehamanniae (crude); Folium Pyrrosiae; Rhizoma Acori Graminei; Rhizoma Dioscoreae Hypoglaucae; Radix Linderae; Herba Cistanche; Radix Paeoniae Rubra; Rhizoma Dioscoreae; Semen Euryales; Cortex Mouton; Polyporus Umbellatus; Radix Rehmanniae Praeparata; Medulla Tetrapanacis; Semen Coicis; Fructus Horedi Germinatus (Poria); Radix Aconiti Praeparata; Rhizoma Alismatis; Cortex Cinnamomi; Herba Asari; Radix Glycyrrhizae; Stigma Maydis; Phaseolus Radiatus L., and optionally, Ganoderma Lucidum.

摘要翻译： 公开了用于预防或治疗前列腺疾病和改善其症状的方法和组合物，包括前列腺炎，良性前列腺增生和前列腺癌。 所述方法包括施用包含以下草药和其它组分的物质组合物：天竺葵; 当归黄芪 黄芪 e 当归; 甘草 皮质杜仲; Medulla Junci; 根瘤菌 Caulis Akebiae; 草药 精液植物 皮质黄柏（油煎）; 枸杞子 白芷根 Ol; 栀子花 黄芪 ae 白芷 没药 石膏纤维素 新西兰根（原油）; 叶子Pyrrosiae; 枸杞子 枸杞子（Rhizoma Dioscoreae Hypoglaucae） 枸杞子 Her肉 白芍 薯 精液Euryales; 皮质木桐 多孔菌 地黄 马杜拉 精液Co is 枸杞（Poria）; 阿根廷 阿利斯蒂斯 Cortex Cinnamomi; 草药Asari 甘草 耻辱Maydis Phaseolus Radiatus L.，以及任选的灵芝（Ganoderma Lucidum）。